Tofacitinib Persistence in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study.

CONCLUSION: Further research is warranted to understand the reasons for discontinuation of tofacitinib despite its ease of administration and to understand the observed differences between switchers and new users.
PMID: 33004534 [PubMed - as supplied by publisher]

Source: Journal of Rheumatology - October 3, 2020 Category: Rheumatology Tags: J Rheumatol Source Type: research